Moderna
FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era
The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.
Breakthrough CMV vaccine offers hope to pregnant women
Health Ministry issues recommendation for Moderna COVID vaccine
Moderna says updated COVID vaccine is effective against newer variant
Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancer
The results add data details to partial findings released by the companies in December.
What's behind the recent Moderna cancer ‘vaccine’ announcement?
World-renowned Hebrew University cancer researcher urges caution about claimed ‘breakthrough’ and terminology.
Sleeping less than six hours will decrease vaccine effectiveness - study
The multi-institution study, published in the peer-reviewed academic journal Current Biology, sheds light on the link between sleep duration and antibody response.
mRNA could make flu vaccines more effective - here's how
The World Health Organization reported that as many as 5 million people suffer from severe cases of influenza each year.
Moderna says new RSV vaccine 84% effective in older adults
Moderna intends to submit the RSV vaccine for regulatory approval in the first half of 2023.
Moderna to launch phase III trials for mRNA cancer vaccine
The mRNA technology used in Moderna's cancer vaccine is built off of what was used in their COVID-19 vaccine.
New Omicron vaccines proven safe and effective
The new boosters are suited to two COVID-19 strains of the Omicron virus variant that represents the vast majority of infections, according to the FDA.
COVID-19: Health Min. offers non-mRNA vaccine, alt. for Pfizer, Moderna
It has obtained supplies of Nuvaxovid from the Novavax company. It is a vaccine that protects against serious complications of the pandemic without being based on mRNA.
EU regulator backs two Omicron-adapted COVID boosters
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.
Pfizer, Moderna's COVID-19 Omicron vaccine boosters approved by US FDA
Pfizer said it has some doses ready to ship immediately and can deliver up to 15 million doses by September 9.
